Longboard Pharmaceuticals, Inc. (LBPH)
NASDAQ: LBPH · IEX Real-Time Price · USD
20.69
+0.18 (0.88%)
At close: May 17, 2024, 4:00 PM
19.66
-1.03 (-4.98%)
After-hours: May 17, 2024, 4:40 PM EDT
Longboard Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for LBPH stock have an average target of 39.71, with a low estimate of 16 and a high estimate of 60. The average target predicts an increase of 91.93% from the current stock price of 20.69.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LBPH stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 5 | 4 | 4 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 8 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +190.00% | May 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $60 | Buy | Reiterates | $60 | +190.00% | May 3, 2024 |
| Wedbush | Wedbush | Buy Maintains $32 → $34 | Buy | Maintains | $32 → $34 | +64.33% | May 3, 2024 |
| Baird | Baird | Buy Initiates $36 | Buy | Initiates | $36 | +74.00% | May 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +190.00% | Apr 16, 2024 |
Financial Forecast
Revenue This Year
2.55M
Revenue Next Year
n/a
from 2.55M
EPS This Year
-1.99
from -2.39
EPS Next Year
-2.48
from -1.99
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 15.8M | n/a | 21.7M | 98.6M | 344.6M |
| Avg | 2.6M | n/a | 7.1M | 56.2M | 224.3M |
| Low | n/a | n/a | n/a | n/a | 13.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 1,291.0% | 513.7% |
| Avg | - | - | - | 692.3% | 299.4% |
| Low | - | - | - | - | -75.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.50 | -2.15 | -2.09 | -3.19 | -1.39 |
| Avg | -1.99 | -2.48 | -2.81 | -3.73 | -2.16 |
| Low | -2.34 | -2.80 | -3.38 | -4.54 | -3.19 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.